SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
晨霭微凉
Lv7
3
3390 积分
2022-05-11 加入
最近求助
最近应助
互助留言
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
2天前
已完结
Targeting KRAS in cancer
2天前
已完结
Phase 1 Studies to Evaluate the Food Effect and Relative Bioavailability of Tablet and Capsule Formulations of Belumosudil in Healthy Adult Subjects
20天前
已完结
SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer
27天前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
1个月前
已完结
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
1个月前
已完结
Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions
1个月前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
2个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
3个月前
已完结
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
3个月前
已完结
没有进行任何应助
感谢
2天前
点赞
2天前
感谢
26天前
感谢
1个月前
点赞
1个月前
感谢
1个月前
速度真快
2个月前
点赞
3个月前
感谢
3个月前
感谢
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论